264 related articles for article (PubMed ID: 19879334)
1. Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice.
Kim H; Kim HY; Choi MR; Hwang S; Nam KH; Kim HC; Han JS; Kim KS; Yoon HS; Kim SH
Neurosci Lett; 2010 Jan; 468(3):190-4. PubMed ID: 19879334
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects.
Habisch HJ; Janowski M; Binder D; Kuzma-Kozakiewicz M; Widmann A; Habich A; Schwalenstöcker B; Hermann A; Brenner R; Lukomska B; Domanska-Janik K; Ludolph AC; Storch A
J Neural Transm (Vienna); 2007; 114(11):1395-406. PubMed ID: 17510731
[TBL] [Abstract][Full Text] [Related]
3. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis.
Vercelli A; Mereuta OM; Garbossa D; Muraca G; Mareschi K; Rustichelli D; Ferrero I; Mazzini L; Madon E; Fagioli F
Neurobiol Dis; 2008 Sep; 31(3):395-405. PubMed ID: 18586098
[TBL] [Abstract][Full Text] [Related]
4. Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice.
Zhao CP; Zhang C; Zhou SN; Xie YM; Wang YH; Huang H; Shang YC; Li WY; Zhou C; Yu MJ; Feng SW
Cytotherapy; 2007; 9(5):414-26. PubMed ID: 17786603
[TBL] [Abstract][Full Text] [Related]
5. Neural induction with neurogenin 1 enhances the therapeutic potential of mesenchymal stem cells in an amyotrophic lateral sclerosis mouse model.
Chan-Il C; Young-Don L; Heejaung K; Kim SH; Suh-Kim H; Kim SS
Cell Transplant; 2013; 22(5):855-70. PubMed ID: 22472631
[TBL] [Abstract][Full Text] [Related]
6. Multiple administrations of human marrow stromal cells through cerebrospinal fluid prolong survival in a transgenic mouse model of amyotrophic lateral sclerosis.
Zhang C; Zhou C; Teng JJ; Zhao RL; Song YQ; Zhang C
Cytotherapy; 2009; 11(3):299-306. PubMed ID: 19333801
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the therapeutic potential of different administration routes and frequencies of human mesenchymal stromal cells in the SOD1
Bursch F; Rath KJ; Sarikidi A; Böselt S; Kefalakes E; Osmanovic A; Thau-Habermann N; Klöß S; Köhl U; Petri S
J Tissue Eng Regen Med; 2019 Apr; 13(4):649-663. PubMed ID: 30811816
[TBL] [Abstract][Full Text] [Related]
8. Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors.
Knippenberg S; Rath KJ; Böselt S; Thau-Habermann N; Schwarz SC; Dengler R; Wegner F; Petri S
J Tissue Eng Regen Med; 2017 Mar; 11(3):751-764. PubMed ID: 25641599
[TBL] [Abstract][Full Text] [Related]
9. Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model.
Marconi S; Bonaconsa M; Scambi I; Squintani GM; Rui W; Turano E; Ungaro D; D'Agostino S; Barbieri F; Angiari S; Farinazzo A; Constantin G; Del Carro U; Bonetti B; Mariotti R
Neuroscience; 2013 Sep; 248():333-43. PubMed ID: 23727509
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stromal cells prolong the lifespan in a rat model of amyotrophic lateral sclerosis.
Forostyak S; Jendelova P; Kapcalova M; Arboleda D; Sykova E
Cytotherapy; 2011 Oct; 13(9):1036-46. PubMed ID: 21736505
[TBL] [Abstract][Full Text] [Related]
11. Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study.
Kim HY; Kim H; Oh KW; Oh SI; Koh SH; Baik W; Noh MY; Kim KS; Kim SH
Stem Cells; 2014 Oct; 32(10):2724-31. PubMed ID: 24966156
[TBL] [Abstract][Full Text] [Related]
12. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
[TBL] [Abstract][Full Text] [Related]
13. Serial in vivo imaging of transplanted allogeneic neural stem cell survival in a mouse model of amyotrophic lateral sclerosis.
Srivastava AK; Gross SK; Almad AA; Bulte CA; Maragakis NJ; Bulte JWM
Exp Neurol; 2017 Mar; 289():96-102. PubMed ID: 28038988
[TBL] [Abstract][Full Text] [Related]
14. Positive effect of transplantation of hNT neurons (NTera 2/D1 cell-line) in a model of familial amyotrophic lateral sclerosis.
Garbuzova-Davis S; Willing AE; Milliken M; Saporta S; Zigova T; Cahill DW; Sanberg PR
Exp Neurol; 2002 Apr; 174(2):169-80. PubMed ID: 11922659
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of human adipose tissue-derived stem cells delays clinical onset and prolongs life span in ALS mouse model.
Kim KS; Lee HJ; An J; Kim YB; Ra JC; Lim I; Kim SU
Cell Transplant; 2014; 23(12):1585-97. PubMed ID: 24070071
[TBL] [Abstract][Full Text] [Related]
16. Transient recovery in a rat model of familial amyotrophic lateral sclerosis after transplantation of motor neurons derived from mouse embryonic stem cells.
López-González R; Kunckles P; Velasco I
Cell Transplant; 2009; 18(10):1171-81. PubMed ID: 19660174
[TBL] [Abstract][Full Text] [Related]
17. Intraspinal injection of human umbilical cord blood-derived cells is neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis.
Knippenberg S; Thau N; Schwabe K; Dengler R; Schambach A; Hass R; Petri S
Neurodegener Dis; 2012; 9(3):107-20. PubMed ID: 22122965
[TBL] [Abstract][Full Text] [Related]
18. Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues.
Corti S; Locatelli F; Donadoni C; Guglieri M; Papadimitriou D; Strazzer S; Del Bo R; Comi GP
Brain; 2004 Nov; 127(Pt 11):2518-32. PubMed ID: 15469951
[TBL] [Abstract][Full Text] [Related]
19. Transplantation of human bone marrow stem cells into symptomatic ALS mice enhances structural and functional blood-spinal cord barrier repair.
Garbuzova-Davis S; Haller E; Navarro S; Besong TE; Boccio KJ; Hailu S; Khatib M; Sanberg PR; Appel SH; Borlongan CV
Exp Neurol; 2018 Dec; 310():33-47. PubMed ID: 30172620
[TBL] [Abstract][Full Text] [Related]
20. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
